Hudson Value Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Hudson Value Partners, LLC
- $290 Billion
- Q2 2025
A detailed history of Hudson Value Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Value Partners, LLC holds 759 shares of REGN stock, worth $423,635. This represents 0.14% of its overall portfolio holdings.
Number of Shares
759Holding current value
$423,635% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,443Shares Held
84.8MCall Options Held
1.4MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.25 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.71 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.16 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.67 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.23 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...